Chris Tran
YOU?
Author Swipe
View article: Supplementary Methods from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Methods from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 181K
View article: Data from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Data from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
In contrast to normal cells, cancer cells avidly take up glucose and metabolize it to lactate even when oxygen is abundant, a phenomenon referred to as the Warburg effect. This fundamental alteration in glucose metabolism in cancer cells e…
View article: Supplementary Figure 3 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 3 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 260K
View article: Supplementary Tables 1-7 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Tables 1-7 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 151K
View article: Supplementary Figure 4 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 4 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 185K
View article: Supplementary Figure Legends 1-4, Methods from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure Legends 1-4, Methods from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
Supplementary Figure Legends 1-4, Methods from 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
View article: Supplementary Methods from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Methods from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 181K
View article: Supplementary Figure 5 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 5 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 483K
View article: Data from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Data from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
Continued reliance on the androgen receptor (AR) is now understood as a core mechanism in castration-resistant prostate cancer (CRPC), the most advanced form of this disease. While established and novel AR pathway–targeting agents display …
View article: Supplementary Tables 1-7 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Tables 1-7 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 151K
View article: Supplementary Figure 1 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 1 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 312K
View article: Supplementary Tables 1-5 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Tables 1-5 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
XLS file - 1.38 MB
View article: Supplementary Tables 1-5 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Tables 1-5 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
XLS file - 1.38 MB
View article: Supplementary Figures 1-4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figures 1-4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
Supplementary Figures 1-4 from 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
View article: Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file- 366K
View article: Supplementary Figure 2 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 2 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 256K
View article: Supplementary Figure 2 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 2 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 256K
View article: Supplementary Figure 2 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 2 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 241K
View article: Supplementary Figure Legends 1-4, Methods from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure Legends 1-4, Methods from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
Supplementary Figure Legends 1-4, Methods from 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
View article: Supplementary Figure 5 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 5 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 483K
View article: Data from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Data from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
In contrast to normal cells, cancer cells avidly take up glucose and metabolize it to lactate even when oxygen is abundant, a phenomenon referred to as the Warburg effect. This fundamental alteration in glucose metabolism in cancer cells e…
View article: Supplementary Figure 3 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 3 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 260K
View article: Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file- 366K
View article: Supplementary Figures 1-4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figures 1-4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
Supplementary Figures 1-4 from 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
View article: Supplementary Figure 2 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 2 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 241K
View article: Supplementary Figure 4 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 4 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 185K
View article: Supplementary Figure 1 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Supplementary Figure 1 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Open
PDF file - 312K
View article: Supplementary Figure 4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 205K
View article: Supplementary Figure 1 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 1 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 206K
View article: Supplementary Figure 4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Supplementary Figure 4 from <sup>18</sup>F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers Open
PDF file - 205K